Graduate Students
63. Anh Minh Thao Nguyen (Ph.D. 04/16 – 11/22, Anti-parasitic agents) Scientist at Theratechnologies Inc., Montreal, QC.
62. Mulamreddy Ramakotaiah (Ph.D. 01/18 – 06/22; NuChem Fellow, Peptide Mimics) Research Scientist, TLC Pharmaceutical Standards Ltd, Toronto, ON.
61. Ginette N'guessan (M.Sc. 01/18 – 06/2020, Azapeptides) Chemical Analyst at KABS Laboratories Inc.
60. Cynthia Crifar (Ph.D. 09/13 – 06/20, Quinolines and Indoles) Scientist, Paraza Pharma Inc. St.-Laurent, QC
59. Julien Poupart (M.Sc. 01/12 – 07/14, Ph.D. 08/14 – 05/20, aminoimidazalones) PDF Inst. Res. Immunol.
Cancer, Montreal.
58. Azade Geranurimi (M.Sc. 01/14 – 12/14; Ph.D. 01/15 – 12/19, Lactam modulators of IL-1beta) Research Scientist at Zamboni Chemical Solution, Montreal, QC
57. Suresh Vutla (M.Sc. 09/17 – 08/19, Cyclic-D,L-azapeptides) Scientist, IntelliSyn Inc., Montreal, QC
56. Nagavenkata Durgaprasad (M.Sc. 01/13 -12/14; Ph.D. 01/15-06/19, Azabicycloalkanone mimics) Senior Synthetic Chemist, NanoVation Therapeutics, Vancouver, BC
55. Fatemeh Mohammadpour (M.Sc. 01/12-05/13, Ph.D. 06/14 – 05/19, FP modulators) Ann Arbor, MI, USA
54. Antoine Douchez (Ph.D. 01/14 – 09/18, Benzatriazepinones) PDF w/Prof. D. Perrin, UBC
53. Ramesh Chingle (Ph.D. 01/13 – 08/18, Azopeptides) PDF w/Prof. T. Burke Jr. Ntl. Inst. Health / National Cancer Institute, USA
52. Kelvine Chignen Possi (M.Sc. 05/14 – 12/17, CD36 ligands) Associate Scientist II, Nuchem Sciences, QC
51. Olivier Van der Poorten (Ph.D. exchange Vrije U. Brussel 07–10/17, Opioid ligands) PDF, VUB
50. Martina De Pascale (Ph.D. exchange U. Caen Normandie 01–08/17, Smac mimics) Ph.D. student UCN
49. Jade Perrichon (M.Sc. exchange UMPC 01/16 – 05/16, Urotensin Receptor Ligands) M.Sc. student UMPC
48. Mbyas Saroukou (M.Sc. 09/13 – 03/16, Pyrroles) Quality control assessor, Plats du Chef Inc., Montreal, QC
47. Julien Dufour (M.Sc. 09/09 – 09/16, Pyrrolodiazepinones) Res. Chemist Asplas Pharma Inc. Montreal, QC
46. Aurélie Dörr (M.Sc., 01/04 - 08/07; Ph.D., 09/07 - Medical Leave, Pyrrolo-Alanines)
45. Martin Strack (Ph.D. exc. Ruhr-U. Bochum 06–11/15, Cyclic peptides) Scientist, Mercachem, Nijmegen, NL
44. Stéphane Turcotte (Ph.D. 09/09 – 08/15, Aminosulfonyldiamides) Principal Research Scientist, X-Chem Inc., Montreal, QC
43. Miriem Boukanoun (M.Sc. 09/11 – 07/15, Azabicycloalkanones) Enseignante à l'université de Tissemsilt , Algerie (maître assistant)
42. Jennifer Rodon Fores (M.Sc. exc. UMPC 01/15 – 09/15, FP modulators) Ph.D. student, Charles Sadron Inst., Strasbourg, FR
41. Ali Munaim Yousif (Ph.D. exchange U. Naples 10/14 – 03/15 UT ligands) Scientist at Axxam, Milan, IT
40. Lylia Dif-Yaïche (M.Sc. exchange UMPC 02/14 – 11/14, Aminosulfurylpeptides) M.Sc. student U. Montréal
39. Francesco Merlino (Ph.D. exchange U. Naples 01/13–12/13 UT ligands) Ass. Prof. Dept. Pharm. U. Naples Federico II, IT
38. Carine Bourguet (Ph.D., 01/04 – 11/12, Prostaglandin Antagonists) Research Associate, Drug Discovery Platform, Medical Research Institute, McGill U. Research Centre, Montreal, QC
37. Tanya Godina (M.Sc., 01/07 – Med. Leave, Cyclic peptides) Assoc., RBC Dominion Sec. Inc., Montréal, QC
36. Caroline Proulx (PhD, 09/07-10/12, Azapeptides) Asst. Prof. Chem., N. Carolina State U., Raleigh, NC, USA
35. Robert Hopewell (M.Sc. 09/09 - Amino Cyclic Ureas) Hospital Radiology Technician, Montréal, QC
34. Kim Beauregard (M.Sc. 09/09 – 02/12 IL1 Modulators) Laboratory Director of Lalema Inc., Montreal, QC
33. Tshibaka Tshitundu (M.Sc., 09/07 – 08/11 Bipyrrole Chemistry) Technician U. Montreal, Montreal, QC
32. Nicolas Genest (M.Sc., 05/05 – 09/10 Homoallylic Ketones) Scientist, L'Oréal, Montreal, QC
31. Wajih Ben Tahar (M.Sc., 09/05 – 09/09 Fluorescent Peptides), Res. Asst., Radiopharmaceutical Quality Assurance and Manufacturing, Montréal, QC
30. Philippe Deaudelin (M.Sc., 06/06 - 02/09, Pyrrole Libraries), Director of Supply Chain, Ropack Pharma Scientist, Montreal, QC
29. Hassan Iden (M.Sc, 09/04 - 04/08, Pyrrolodiazepinones), PDF, U. Laval, Quebec City, QC
28. Benoit Jolicoeur (M.Sc., 01/04 - 06/07, Prodigiosins) R&D Manager, General Dynamics, Montréal, QC
27. Zohreh Sajjadi (M.Sc., 09/03 - 06/07, Azetidines) Medicinal/Organic Chemist, AMRI, Albany, NY, USA
26. Christophe Pardin (Ph.D., co-dir. w/J. Keillor, 05/03 - 05/07, TGase Inhibitors), Prof. de l'Outaouais College, Ottawa, ON
25. Charles Banville (M.Sc., 09/02 - 07/06, Pyrrolizidinones) Scientist, L'Oréal, Montreal, QC
24. Simon Suprenant (M.Sc., 09/03 - 01/06, Azabicycloalkanes) Senior Scientist, Repare Therapeutics, Montreal, QC
23. Yann Brouillette (M.Sc., 09/03 - 09/05, Pyrrole Libraries), Prof. Chem. Dawson College, Montréal, QC
22. Fabrice Galaud (M.Sc., 09/01- 08/05, Amino Lactams) Res. Asst., IRIC, U. Montréal, Montréal, QC
21. Guillaume Jeannotte (M.Sc., 09/01- 09/04, Pyrrolo-Prolines) Scientist, L'Oréal, Montreal, QC
20. James Dettwiler (M.Sc., 01/01 - 08/04, Aureobasidin mimics) Scientific Advisor, Etat du Canton de Vaud, CH
19. Jérome Cluzeau (Ph.D. 09/98 - 08/04, CGRP Peptide Mimics) Sr. Scientist, Lek Pharma. Menges, Slovenia
18. Felix-A. Marcotte (M.Sc. 09/01-08/04, NSERC Sch., Aminopyrroles) Prof., St. Jerome College, St Jerome, QC
17. Catherine Girard (M.Sc. 05/01-09/03, NSERC Scholar, Hdac Inhibitors) Med. School, Montréal, Montreal, QC
16. Evelyn Dietrich (M.Sc. 08/00- FCAR Scholar 00-02, pyrrolizidinones) Sr. Scientist, Repare Therapeutics, Montreal, QC
15. Laurent Bélec (M.Sc. 09/95 - 12/96, Ph.D. 01/97 - 11/02, 5-t-BuPro Oxytocin Mimics) Director of Product Development, Novocol Pharm, Cambridge, ON
14. Kenza Daiiri (M.Sc. 05/98 - 03/02, Protease mimicry) Corp. Partnerships Exec., Rethink Mental Illness, London, UK
13. Liliane Halab (Ph.D. 05/96 - 03/02, NSERC Sch., Type VI turns) Prof. Marianopolis College. Westmount, QC
12. Simon Roy (M.Sc. 06/97 - 05/01; FCAR Sch., Gramicidin S Mimics) Scientist, Methylgene Inc., Montréal. QC
11. Eryk Thouin (M.Sc., NSERC Sch.; Res. Asst. 07/01- 04/04, Enz. inhibitors) Scientist, BioAxone, Montreal, QC
10. Zhe Feng (M.Sc. 09/97 - 09/00, Indolizidinone Amino Acids) Scientist, Novartis Res. Corp., Summit, NY, USA
9. Lan Wei (M.Sc. 08/97 - 06/00, AMPA-like Isoxazole Amino Acids) Scientist, Merck, Rahway, NJ, USA
8. Francis Gosselin (M.Sc. 09/95 - 12/96, Ph.D. 01/97 - 01/00, NSERC scholar, Heterocyclic Peptides) Director, Head of Process Chemistry, Genentech, San Francisco, CA, USA
7. Eric Beausoleil (M.Sc. 05/92 - 05/94, Ph.D. 05/94 - 09/99, Alkylprolines) Director Business Development Europe, SiliCycle Inc., Paris, France
6. Dany Rondeau (M.Sc. 06/97 - 12/98, Kainoids) Professor, Andre-Grasset College, Montreal, QC
5. Henry-Georges Lombart (Ph.D. 09/92 - 09/97, Indolizidinones) Project Mgr., Chem. AsisChem, Boston, MA, USA
4. Patrice Gill (M.Sc. 01/94 - 05/97, Kainoids) Principal Scientist Oncology, Bristol Myers Squibb, Lawrenceville, New Jersey, USA
3. Trang Pham (M.Sc. 05/92 - 05/93; Ph.D. 05/93 - 02/97, Bio-Méga Scholar, Enantioselective hydrogenation) PDF w/ Prof. R. Noyori, U. Nagoya, presently QA Auditor for Quintiles AB, Uppsala, Sweden.
2. Benoit L'Archevèque (M.Sc. 09/93 - 09/95, NSERC Scholar, 5-t-BuPro7-OT) Marketing Intelligence Analyst, Novartis, Montreal, QC
1. Mohamed Atfani (M.Sc. 01/93 - 05/94 Isoxazole Amino Acids) Research Asst. U. Montréal, Montréal QC
Post-doctoral fellows
40. Léonie Cussol (01/20 – 06/20) Docteur en chimie organique, Aix-en-Provence, Provence-Alpes-Côte d’Azur, France
39. Pradeep Chauhan (01/18 – 01/20,Cyclic azapeptide diagnostics of amyloid formation) PDF York University
38. Ragnhild Ohm (01/16 – 08/18, Peptide mimicry using the 3A reaction) Scientist, H. Lundbeck A/S, Denmark
37. Ahsanullah (04/15 – 10/16 CD36 peptide mimic ligands) Assistant Professor Department of Chemistry, University of Quaid-I-Azan, Islamabad, Pakistan
36. Mariam Traore (05/13 – 04/16 Aza-Arginine Peptides) Assistant Professor, University of Bamako, Mali
35. Jinqiang Zhang (04/13 – 01/16 Aza-Lysine Peptides) Assistant Professor Chongqing U., China
34. Yessica Garcia-Romas (10/10 – 10/15, CD36 Ligands) Scientist NuChem Pharma Montreal, QC
33. Carine Bourguet (11/12 – 11/13 Prostaglandin Modulators) Associate Director of Operations and uNMR at NMX Research and Solutions Inc., QC
32. Stefan Soderman (09/13 – 10/14 Thiosemicarbazides) Business Development Director - North America Biosynth AG
31. Doan Ngoc Duc (06/12 – 08/14 Amino Cyclic Urea) PDF MIT; Scientist III NextCure, Beltsville, MD, USA
30. Tarek Kassem (11/06 – 05/12, PVA-PEG Chemistry) Founder Izi-Chem Inc., Montréal, QC
29. Daniel St-Cyr (08/08–02/12, Hydroxy Amino Lactam) Senior Research Scientist at X-Chem Inc., Montreal, QC
28. Nicolas Boutard (05/07 – 04/11, Amino-Lactams) Senior Scientist II Ryvu Therapeutics, Krakow, Poland
27. David Sabatino (04/07 – 07/10, Azapeptides), Associate Professor, Department of Chemistry, Carleton University, ON
26. Luisa Ronga (03/08 – 06/09, Lactam Mimics), Asst. Prof. Chem., U. de Pau et des Pays de l’Adour, Pau, FR
25. Gil Fridkin (08/03 - 12/08, Deazapurines), Scientist, Israel Inst. for Biol. Research, Ness-Ziona, Israel
24. Wang Chen (11/07 - 10/08, IL1 Ligands), Process Chemist, Thesis Chem. Inc., Cambridge, ON
23. Andrew Jamieson (01/07 - 08/08, Amino Lactam Mimics) Professor of Chemical Biology, School of Chemistry, Glasgow University, UK
22. Teresa Lama (09/05 - 02/07, Hydroxyethylene Isosteres) Director of Pharmacy Services at Jean Coutu Pharmacy Montreal, QC
21. Louis Watanabe (05/06 - 01/07, Amino Lactams) Director, Watanabe Chem. Ind., Hiroshima City, Japan
20. Susan Seaman (01/05 - 07/06, Quinolizidinone Mimics) Assistant Teaching Professor, Notre Dame University, USA
19. John Blankenship (06/03 - 05/06, Sheet Mimics) Senior Scientist, Aptevo Therapeutics, Seattle, USA
18. Mandar Bodas (10/04 - 03/06, Amino Lactams) Scientist, Syngene International Ltd., India
17. Ramana Rao (03/04 - 03/06, Pyrrolizidinones) Senior Group Leader at Aurigene Discovery Technologies Ltd Bengaluru, Karnataka, India
16. Juntao Luo (09/04 - 09/05, PVA-PEG Resin) Asst. Prof. Pharmacol. Upstate Medical U., SUNY Syracuse, USA
15. Damien Boeglin (01/04 - 08/05, Aza-Peptides) Alsachim Bioparc, Graffenstaden, France
14. Martin Gagnon (co-dir. w/U. Saragovi, 09/03 - 03/05, GD2 Ligands) Scientist, Chlorion Pharma, Quebec, QC
13. Karl Hansford (03/03 - 05/05, Cytokine Ligands) Scientist, Boron Molecular, Melbourne Australia
12. Ramesh Kaul (05/02 - 03/05, GPCR Ligands) Scientist, NeuroMed, Vancouver, BC
11. Rosa Melendez (03/01 - 11/03, FCAR Fellow, Azapeptides) Scientist, Goodmans LLP, Toronto, ON
10. Wim de Borggraeve (03/03 - 08/03, Pyrrolizidinones) Assistant Professor, Katholieke U. Leuven, Belgium
9. Frederik Rombouts (10/02 - 07/03, Deazapurines) Scientist, Jensen Pharma, Belgium
8. Mohamed Atfani (06/00 - 01/01, Glu-Receptor Ligands) Research Asst. U. Montreal, Montreal, QC
7. Hovsep Avedissian (06/00 - 03/01, Rho- Kinase Ligands) PDF w/ Pr. Ganesan, Southampton U., UK
6. Jo van Betsbrugge (09/97 - 05/00, Azasugar Mimics) President, CMC-Rx Consultancy, Laval, QC
5. Felix Polyak (03/97 - 07/99, FP Ligands) Chief Operating Officer, Aluron Biopharma Inc. Montreal, QC
4. Martin Swarbrick (Glaxo Fellow, 01/98 - 06/99, Alkylpipecolates) Scientist, Glaxo, Stevenage, UK
3. Mostafa Hatam (10/97 - 06/99, Azasugar Synthesis) Scientist, Aapptec Inc., USA
2. Raman Sharma (10/93 - 07/95, beta-Alkylprolines) PDF w/ Professor S. Hanessian, U. Montréal, QC
1. Houda Haj Ibrahim (10/91 - 08/93, Alkylprolines) Research Scientist, Separation Technologies, USA